Revance

In honor of #BreastCancerAwarenessMonth, we recognize the importance of early screenings and prevention in the fight against breast cancer. The American Cancer Society estimates that in 2024, approximately 310,720 women will be diagnosed with invasive breast cancer—16% of whom will be under 50. And it’s not just women; around 2,790 men are also expected to be diagnosed. At Revance, we’re committed to supporting our employees through comprehensive health and wellness programs. Our preventative health plans cover a variety of health checkups, including routine screenings and mammograms, along with wellness programs that offer guidance on maintaining a healthy lifestyle, reducing risk factors, and managing stress. Early detection saves lives. Join us in prioritizing health and well-being through regular screenings. #BreastCancerAwareness #EmployeeWellbeing #EarlyDetection #RVNC #SettingtheNewStandard

We're excited to share that our Phase 2 study, JUNIPER, investigating the efficacy and safety of DAXXIFY® in adults with upper limb spasticity has just been published online in PM&R. We would like to thank our collaborators, Atul Patel, MD, Michael Munin, Ziyad Ayyoub and Gerard Francisco, M.D. for their contributions to this work. DAXXIFY® showed statistically significant improvements in score on the Modified Ashworth Scale (MAS), a tool used to measure the amount of excessive muscle tone, with a 500U dose. To learn more, please click to read the full publication: https://lnkd.in/ehEZWW3b #DAXXIFY #UpperLimbSpasticity #Neurologists #RevanceScience #SettingtheNewStandard Watch for Important Safety Information. For Full Prescribing Information, including Boxed Warning and Medication Guide, see https://lnkd.in/etBtYw-S DAXXIFY® (daxibotulinumtoxinA-lanm) is a prescription medicine that is injected into muscles and used to treat cervical dystonia in adults. Ask your doctor to tell you about DAXXIFY®. DAXXIFY® may cause serious side effects hours to weeks after injection. Alert your doctor right away as difficulty swallowing, speaking, and breathing due to weakening of associated muscles can be a sign of a life-threatening condition. The most common side effects are headache, injection site pain, injection site redness, muscle weakness, and upper respiratory tract infection.

Heading to ASDS? Join Revance Aesthetics throughout the meeting! - Join us for a Hot Topics cocktails and hors d’oeuvres reception on Thursday, October 17 from 7PM – 9PM. - Attend our industry expert discussion, Unlocking Dynamic and Natural Results with the RHA® Collection, featuring Dr. Lee Walker and Dr. Susan Weinkle on Friday, October 18 from 6PM – 7PM in the Exhibit Hall. Please note that you must be registered for ASDS. Contact your Professional Aesthetic Consultant for details. #RVNC #RevanceAesthetics #ASDS #SettingtheNewStandard

Today, we proudly celebrate Hispanic Heritage Month and this year’s theme - Pioneers of Change: Shaping the Future Together. We honor the Hispanic and Latino communities for their ongoing contributions to shaping innovation, culture, and society. From trailblazers in business to pioneers in arts and science, Hispanic and Latino individuals are continuously driving positive change and inspiring future generations. Celebrate with us and check out https://lnkd.in/eEsG_kg to learn more. #HispanicHeritageMonth #PioneersOfChange #LatinoHeritage #RVNC

Today, we remember the lives lost on September 11th, 2001. We honor the courage of the first responders and the resilience of all those affected. Together, we stand in remembrance and unity. #NeverForget

It’s the 2nd anniversary of the award-winning #DAXXIFY and we have so much to celebrate! 🎉 First and only peptide-powered frown line treatment. 🎉 The benefits are clear: Fast. Lasts. And the Look. 🎉 More and more awards! We can’t wait for more to come with your continued support. See what’s to love about DAXXIFY® at daxxify.com #Cheers2Daxxify #RVNC #SettingtheNewStandard Results as early as the next day and typically within 2 days. At least 50% of patients in clinical studies had no or minor frown lines 6 months after treatment. Improves the appearance of skin texture versus before treatment. 64% of patients achieved an improvement in the appearance of skin texture at week 2 from a post hoc analysis of a Phase 2 clinical study with 60 patients. For DAXXIFY® Full Prescribing Information including Boxed Warning and Medication Guide, seehttps://lnkd.in/etBtYw-S. DAXXIFY®(daxibotulinumtoxinA-Ianm) is a prescription medicine for adults to temporarily improve the look of moderate to severe frown lines between the eyebrows. Ask your doctor to tell you about DAXXIFY®. DAXXIFY® may cause serious side effects hours to weeks after injection. Alert your doctor right away as difficulty swallowing, speaking, breathing, eye problems or muscle weakness can be a sign of a life-threatening condition. The most common side effects are headache, eyelid drooping, and loss of the ability to move some muscles in your face. Call your doctor for medical advice about side effects. Intended for US audiences. From TIME. ©2023 TIME USA LLC. All rights reserved. Used under license

Happy Labor Day! Today, we honor the history of hard work and dedication that built our nation. #LaborDay #Celebrate #HardWork #RVNC #SettingtheNewStandard

Our very own Chief Scientific Officer, Conor Gallagher, was interviewed on this week's episode of The Technology of Beauty. Tune in to hear what he has to say about the #RevanceAesthetics portfolio. #SettingtheNewStandard #RVNC #Aesthetics

Thank you to all who attended the “Breaking through Barriers in a Competitive Market" education event at Revance headquarters this past weekend, and a special thank you to Dr. Michael Lafkas, David Weir, NP and Dr. Lee Walker for sharing your expertise! Interested in learning more about #revanceaesthetics? Check out our website https://lnkd.in/dmrWgQQh #SettingtheNewStandard #RVNC #Aesthetics

It’s the four-year anniversary of the #RHACollection and we’ve got so many reasons to celebrate! We’ve just hit a major milestone of selling more than ONE MILLION boxes of our award-winning fillers, and we continue to be the fastest growing #HyaluronicAcid filler brand in the US. Thanks a MILLION to our partner practices for embracing innovation and supporting us over the past four years. How are you celebrating RHA®? If you haven’t tried the RHA® Collection yet, now’s the time to see what the hype is all about. Learn more at rhacollection.com. #HAFiller #FillerInjections #SettingtheNewStandard #RVNC